Effects of Interactive Sensory Play on Manual Dexterity in Down Syndrome
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Apr 17, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how interactive sensory play can help improve hand movements, known as manual dexterity, in children with Down Syndrome. Down Syndrome is a genetic condition that can affect a child's physical and mental abilities, making everyday activities more challenging. In this trial, children diagnosed with moderate intellectual disabilities who can follow simple commands will participate. However, children with other serious health issues, like certain neurological or heart conditions, will not be included.
The trial will take place at the Tehsil Headquarter Hospital in Sadiqabad over a period of 10 months. Participants will be randomly assigned to one of two groups: one group will engage in interactive sensory play activities, while the other group will have free play. This means that some children will be playing with specially designed toys and activities, while others will play freely without specific guidance. The goal is to see if the structured play helps improve their hand coordination better than regular play. If you or your child qualify and decide to participate, you will be part of a study aimed at finding ways to help children with Down Syndrome improve their skills and enjoy a better quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children with moderate level of mental retardation who are able to follow commands
- Exclusion Criteria:
- • • Children with other musculoskeletal and neurological issues.
- • Children with down syndrome but also have complications such as epilepsy, congenital heart condition.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Taiba Hussain, MS-PPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported